Melange combination

NDC 62106-1235 · Seroyal USA

Generic nameCalcarea sulphurica, Calcium phosphoricum, Kali muriaticum, Kalium phosphoricum, Kali sulphuricum, Magnesia phosphorica, Natrum muriaticum, Natrum phosphoricum, Natrium sulfuricum, Calcarea fluorica, Ferrum phosphoricum, Silicea

Dosage formTABLET

RouteORAL

Active ingredient(s)CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, CALCIUM SULFATE ANHYDROUS, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SILICON DIOXIDE, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, SODIUM CHLORIDE, SODIUM SULFATE, CALCIUM FLUORIDE, FERROSOFERRIC PHOSPHATE

Strength12; 6; 6; 12; 6; 6; 6; 6; 12; 6; 6; 6 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1

Pharmacologic classBlood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Marketing categoryUNAPPROVED HOMEOPATHIC

Packages

62106-1235-2 — 1 BOTTLE, GLASS in 1 BOX (62106-1235-2) / 100 TABLET in 1 BOTTLE, GLASS

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62106-1053 — Hydrated iron III phosphate, 62106-1054 — Potassium Chloride, 62106-1056 — Potassium sulfate, 62106-1057 — Magnesium hydrogen phosphate trihydrate, 62106-1058 — Sodium chloride, 62106-1060 — Anhydrous sodium sulfate, 62106-1061 — Silicea, 62106-1171 — Berberis vulgaris, Calcarea fluorica, 62106-1176 — Aurum metallicum, Calcarea fluorica, Cuprum metallicum, Gelsemium sempervirens, Sulphur, 62106-1195 — Antimonium sulphuratum aureum, Arsenicum iodatum, Blatta orientalis, Eriodictyon californicum, Ipecacuanha, Lobelia inflata, Natrum…, 62106-9916 — Arnica montana, Calcarea phosphorica, Calendula officinalis, Hypericum perforatum, Medullosseinum, Pulsatilla, Ruta graveolens, Symphytum…, 62185-0024 — Adenosinum Triphosphoricum Dinatrum, Pantothenic Acid, Pineal Gland (Suis), Sarcolacticum Acidum, Ubidecarenonum, L-Tryptophan, Melatonin,…, 62185-0043 — Berberis Vulgaris, Cimicifuga Racemosa, Cinchona Officinalis, Colocynthis, Ledum Palustre, Ranunculus Bulbosus, Aesculus Hippocastanum,…, 62185-0054 — Dulcamara, Echinacea (Angustifolia), Aesculus Hippocastanum, Antimonium Tartaricum, Ascorbicum Acidum, Coccus Cacti, Galium Aparine,…, 62185-0063 — Coumarinum, Quercetin, Rutin, Bamboo, Barley, Poppy Seed, Corn (Zea Mays), Flax Seed (Linum Usitatissimum), Buckwheat (Fagopyrum…, 62207-726 — Potassium Chloride Extended-release, 62207-727 — Potassium Chloride Extended-release, 62207-914 — Potassium Chloride, 62207-915 — Potassium Chloride, 62795-1005 — DIOSCOREA VILLOSA TUBER, SODIUM CHLORIDE, and STRYCHNOS NUX-VOMICA SEED, +2735 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels